These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38002259)

  • 21. Heart failure with mid-range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF).
    Rickenbacher P; Kaufmann BA; Maeder MT; Bernheim A; Goetschalckx K; Pfister O; Pfisterer M; Brunner-La Rocca HP;
    Eur J Heart Fail; 2017 Dec; 19(12):1586-1596. PubMed ID: 28295985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Implications of Functional Mitral Regurgitation Severity in Patients with Heart Failure with Reduced Ejection Fraction (HFrEF).
    Naser N
    Med Arch; 2022 Feb; 76(1):17-22. PubMed ID: 35422569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: a post-hoc analysis of the ATHENA trial.
    Vaduganathan M; Piccini JP; Camm AJ; Crijns HJGM; Anker SD; Butler J; Stewart J; Braceras R; Albuquerque APA; Wieloch M; Hohnloser SH
    Eur J Heart Fail; 2022 Jun; 24(6):1094-1101. PubMed ID: 35293087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Layer-specific strain in patients with heart failure using cardiovascular magnetic resonance: not all layers are the same.
    Xu L; Pagano JJ; Haykowksy MJ; Ezekowitz JA; Oudit GY; Mikami Y; Howarth A; White JA; Dyck JRB; Anderson T; Paterson DI; Thompson RB;
    J Cardiovasc Magn Reson; 2020 Dec; 22(1):81. PubMed ID: 33267877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Empagliflozin: A Review in Symptomatic Chronic Heart Failure.
    Frampton JE
    Drugs; 2022 Nov; 82(16):1591-1602. PubMed ID: 36374374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic and prognostic value of the electrocardiogram in stable outpatients with type 2 diabetes.
    Gregers MCT; Schou M; Jensen MT; Jensen J; Petrie MC; Vilsbøll T; Goetze JP; Rossing P; Jørgensen PG
    Scand Cardiovasc J; 2022 Dec; 56(1):256-263. PubMed ID: 35811473
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of paced heart rate on quality of life and natriuretic peptides for stage B or C heart failure with preserved ejection fraction: A secondary analysis of the myPACE trial.
    de la Espriella R; Wahlberg KJ; Infeld M; Palau P; Núñez E; Sanchis J; Meyer M; Núñez J
    Eur J Heart Fail; 2024 Jan; 26(1):167-176. PubMed ID: 38124404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics and clinical outcomes of patients with acute heart failure with a supranormal left ventricular ejection fraction.
    van Essen BJ; Tromp J; Ter Maaten JM; Greenberg BH; Gimpelewicz C; Felker GM; Davison BA; Severin T; Pang PS; Cotter G; Teerlink JR; Metra M; Voors AA
    Eur J Heart Fail; 2023 Jan; 25(1):35-42. PubMed ID: 36114655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A retrospective analysis of clinical characteristics and outcomes of heart failure patients with different left ventricular ejection fractions].
    Zhou HB; An DQ; Zhan Q; Liu ZH; Hua JH; Lai WY; Huang YL; Zeng QC; Xu DL
    Zhonghua Nei Ke Za Zhi; 2017 Apr; 56(4):253-257. PubMed ID: 28355716
    [No Abstract]   [Full Text] [Related]  

  • 30. Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction.
    Straw S; Cole CA; McGinlay M; Drozd M; Slater TA; Lowry JE; Paton MF; Levelt E; Cubbon RM; Kearney MT; Witte KK; Gierula J
    Clin Res Cardiol; 2023 Jan; 112(1):111-122. PubMed ID: 35781605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left ventricular ejection fraction as therapeutic target: is it the ideal marker?
    Katsi V; Georgiopoulos G; Laina A; Koutli E; Parissis J; Tsioufis C; Nihoyannopoulos P; Tousoulis D
    Heart Fail Rev; 2017 Nov; 22(6):641-655. PubMed ID: 28601914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes.
    Nadruz W; West E; Santos M; Skali H; Groarke JD; Forman DE; Shah AM
    Circ Heart Fail; 2016 Apr; 9(4):e002826. PubMed ID: 27009553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical features and prognosis of patients with different types of heart failure in relation to coronary artery disease].
    Zhou Y; Mo T; Bao YP; Wang L; Zhong RR; Tian JL
    Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(15):1142-1147. PubMed ID: 32311877
    [No Abstract]   [Full Text] [Related]  

  • 34. Impact of left ventricular ejection fraction on clinical outcomes after left main coronary artery revascularization: results from the randomized EXCEL trial.
    Thuijs DJFM; Milojevic M; Stone GW; Puskas JD; Serruys PW; Sabik JF; Dressler O; Crowley A; Head SJ; Kappetein AP
    Eur J Heart Fail; 2020 May; 22(5):871-879. PubMed ID: 32043709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trajectory change of left ventricular ejection fraction after rhythm control for atrial fibrillation in heart failure.
    Si J; Sun Y; Bai L; Tse G; Ding Z; Zhang X; Zhang Y; Chen X; Xia Y; Liu Y
    ESC Heart Fail; 2024 Apr; 11(2):681-691. PubMed ID: 38097279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Five-year mortality of heart failure with preserved, mildly reduced, and reduced ejection fraction in a 4880 Chinese cohort.
    Chen S; Huang Z; Liang Y; Zhao X; Aobuliksimu X; Wang B; He Y; Kang Y; Huang H; Li Q; Yao Y; Lu X; Qian X; Xie X; Liu J; Liu Y
    ESC Heart Fail; 2022 Aug; 9(4):2336-2347. PubMed ID: 35437939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal evaluation of ventricular ejection fraction and NT-proBNP across heart failure subgroups.
    Martinsson A; Oest P; Wiborg MB; Reitan Ö; Smith JG
    Scand Cardiovasc J; 2018 Aug; 52(4):205-210. PubMed ID: 29656687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness and safety of transcatheter aortic valve replacement in elderly people with severe aortic stenosis with different types of heart failure.
    Dong M; Wang L; Tse G; Dai T; Wang L; Xiao Z; Liu T; Ren F
    BMC Cardiovasc Disord; 2023 Jan; 23(1):34. PubMed ID: 36653770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of cardiac I-123-metaiodobenzylguanidine imaging in patients with reduced, mid-range, and preserved left ventricular ejection fraction admitted for acute decompensated heart failure: a prospective study in Osaka Prefectural Acute Heart Failure Registry (OPAR).
    Seo M; Yamada T; Tamaki S; Watanabe T; Morita T; Furukawa Y; Kawasaki M; Kikuchi A; Kawai T; Abe M; Nakamura J; Yamamoto K; Kayama K; Kawahira M; Tanabe K; Kimura T; Ueda K; Sakamoto D; Sakata Y; Fukunami M
    Eur Heart J Cardiovasc Imaging; 2021 Jan; 22(1):58-66. PubMed ID: 32091079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of heart failure patients with mid-range left ventricular ejection fraction-a report from the CHART-2 Study.
    Tsuji K; Sakata Y; Nochioka K; Miura M; Yamauchi T; Onose T; Abe R; Oikawa T; Kasahara S; Sato M; Shiroto T; Takahashi J; Miyata S; Shimokawa H;
    Eur J Heart Fail; 2017 Oct; 19(10):1258-1269. PubMed ID: 28370829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.